Altered chaperone-nonmuscle myosin II interactions drive pathogenicity of the UNC45A c.710T>C variant in osteo-oto-hepato-enteric syndrome.
Waich S. et al, (2025), JCI insight, 10
Upadacitinib for Induction of Remission in Paediatric Crohn's Disease: An International Multicentre Retrospective Study.
Cohen S. et al, (2025), Alimentary pharmacology & therapeutics
Effectiveness and Safety of Adalimumab in Patients With Very Early-Onset Inflammatory Bowel Disease: A Retrospective Study on Behalf of the Porto Inflammatory Bowel Disease Working Group of European Society for Pediatric Gastroenterology Hepatology and Nutrition.
Weintraub Y. et al, (2025), Inflammatory bowel diseases
Upadacitinib for Induction of Remission in Pediatric Ulcerative Colitis: An International Multi‑center Study.
Yerushalmy-Feler A. et al, (2024), J Crohns Colitis
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease
Thomas T. et al, (2024), Nature Immunology, 25, 2152 - 2165
Cellular and molecular basis of proximal small intestine disorders.
Bildstein T. et al, (2024), Nature reviews. Gastroenterology & hepatology, 21, 687 - 709
The circulating methylome in childhood-onset inflammatory bowel disease.
Noble A. et al, (2024), Journal of Crohn's & colitis
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia.
Saettini F. et al, (2024), Journal of clinical immunology, 45
Successful Allogeneic Hematopoietic Cell Transplantation for Patients with IL10RA Deficiency in Japan.
Tomomasa D. et al, (2024), Journal of clinical immunology, 45
Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease.
Griffin H. et al, (2024), The New England journal of medicine, 391, 434 - 441
Short-chain fatty acids: linking diet, the microbiome and immunity.
Mann ER. et al, (2024), Nature reviews. Immunology, 24, 577 - 595
Intestinal Inflammation and Extraintestinal Disease: Understanding Dynamic Risk.
Ashton JJ. et al, (2024), Gastroenterology, 167, 205 - 208
Genomic testing identifies monogenic causes in patients with very early-onset inflammatory bowel disease: a multicenter survey in an Iranian cohort.
Eslamian G. et al, (2024), Clinical and experimental immunology, 217, 1 - 11
Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease.
Salihovic S. et al, (2024), Nature communications, 15
The impact of inversions across 33,924 families with rare disease from a national genome sequencing project
Pagnamenta AT. et al, (2024), The American Journal of Human Genetics, 111, 1140 - 1164
An isoform quantitative trait locus in SBNO2 links genetic susceptibility to Crohn's disease with defective antimicrobial activity.
Aschenbrenner D. et al, (2024), Nature communications, 15
Catalyzing change: Implementing standardised reporting in monogenic inflammatory bowel disease research
Yeh P. et al, (2024), Journal of Pediatric Gastroenterology and Nutrition, 78, 759 - 762
Author Correction: Inflammation across tissues: can shared cell biology help design smarter trials?
Hosack T. et al, (2024), Nature Reviews Rheumatology, 20, 63 - 63
Elucidating the clinical spectrum and expanding genotype-phenotype associations in PI4KA-related disorder
Salter C. et al, (2024), EUROPEAN JOURNAL OF HUMAN GENETICS, 32, 882 - 883
High diagnostic accuracy of 4-probe methylation biomarkers in paediatric Inflammatory Bowel Disease by epigenome-wide analysis
Noble A. et al, (2024), JOURNAL OF CROHNS & COLITIS, 18, I172 - I174